Holen Sie sich die Stockscreener-App
199.64
1.93%
-3.92
Handel nachbörslich:
200.18
0.54
+0.27%
Schlusskurs vom Vortag:
$203.56
Offen:
$204.35
24-Stunden-Volumen:
2.33M
Relative Volume:
1.08
Marktkapitalisierung:
$42.20B
Einnahmen:
$447.02M
Nettoeinkommen (Verlust:
$-1.18B
KGV:
-32.30
EPS:
-6.1812
Netto-Cashflow:
$-906.14M
1W Leistung:
+4.55%
1M Leistung:
+18.90%
6M Leistung:
+191.40%
1J Leistung:
+174.72%
1-Tages-Spanne:
$199.00
$208.00
1-Wochen-Bereich:
$187.55
$208.00
52-Wochen-Spanne:
$60.40
$208.00
Insmed Inc Stock (INSM) Company Profile
Firmenname
Insmed Inc
Sektor
Branche
Telefon
908-977-9900
Adresse
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Vergleichen Sie INSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-28 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2025-10-20 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-20 | Eingeleitet | William Blair | Outperform |
| 2025-08-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-05-13 | Eingeleitet | Jefferies | Buy |
| 2025-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-04-23 | Eingeleitet | Truist | Buy |
| 2024-02-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-11-20 | Fortgesetzt | JP Morgan | Overweight |
| 2023-07-26 | Eingeleitet | Guggenheim | Buy |
| 2022-12-09 | Eingeleitet | Mizuho | Buy |
| 2022-12-07 | Eingeleitet | Barclays | Overweight |
| 2022-11-18 | Eingeleitet | BofA Securities | Buy |
| 2022-04-27 | Eingeleitet | Goldman | Buy |
| 2021-12-06 | Eingeleitet | JP Morgan | Overweight |
| 2021-10-19 | Fortgesetzt | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Fortgesetzt | Morgan Stanley | Overweight |
| 2021-10-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-17 | Eingeleitet | Berenberg | Buy |
| 2020-10-12 | Fortgesetzt | Stifel | Buy |
| 2019-09-03 | Eingeleitet | Goldman | Buy |
| 2019-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-15 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Hochstufung | Goldman | Neutral → Buy |
| 2019-01-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-08-06 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Eingeleitet | Goldman | Neutral |
| 2018-04-23 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Eingeleitet | Morgan Stanley | Overweight |
| 2018-01-18 | Eingeleitet | Credit Suisse | Neutral |
| 2017-09-05 | Bestätigt | Evercore ISI | Outperform |
| 2017-08-17 | Eingeleitet | Evercore ISI | Outperform |
| 2017-07-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2016-03-15 | Eingeleitet | Stifel | Buy |
| 2015-11-09 | Herabstufung | UBS | Buy → Neutral |
| 2015-10-06 | Bestätigt | H.C. Wainwright | Buy |
| 2015-06-09 | Eingeleitet | Citigroup | Neutral |
| 2014-03-26 | Bestätigt | HC Wainwright | Buy |
Alle ansehen
Insmed Inc Aktie (INSM) Neueste Nachrichten
INSM: TD Cowen Raises Price Target, Maintains Buy Rating | INSM Stock News - GuruFocus
How Insmed Incorporated (IM8N) stock performs in easing cyclesRate Hike & Daily Stock Trend Reports - newser.com
Will Insmed Incorporated (IM8N) stock recover faster than industryFed Meeting & High Accuracy Swing Entry Alerts - newser.com
Insmed wins first EU approval for non-cystic fibrosis bronchiectasis treatment - MarketScreener
Why Insmed Incorporated (IM8N) stock is listed among top recommendationsPortfolio Performance Report & AI Forecast Swing Trade Picks - newser.com
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - sharewise.com
Will Insmed Incorporated stock benefit from automationIndex Update & Accurate Entry/Exit Alerts - newser.com
From Olema To Insmed: Are These High-Flying Biotechs Still Worth Buying? - RTTNews
Insider Sell: Leo Lee Sells 75,000 Shares of Insmed Inc (INSM) - GuruFocus
Building trade automation scripts for Insmed IncorporatedCPI Data & Proven Capital Preservation Methods - newser.com
Insmed director Anderson sells $1.96 million in stock By Investing.com - Investing.com South Africa
Insmed director Anderson sells $1.96 million in stock - Investing.com
Peering Into Insmed Inc's Recent Short Interest - Benzinga
Insmed (INSM) Gains EU Approval for First NCFB Treatment - GuruFocus
European Commission Approves BRINSUPRI® (brensocatib) as the First and Only Treatment To Date Approved for Non-Cystic Fibrosis Bronchiectasis in the European Union - PR Newswire
Insmed (Nasdaq: INSM) BRINSUPRI Wins EU OK After 19.4% NCFB Exacerbation Reduction - Stock Titan
European Commission Approves Insmed's Chronic Lung Disease Treatment - MarketScreener
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity By Investing.com - Investing.com Nigeria
Insmed at Jefferies London: Transforming into a Multi-Franchise Entity - Investing.com
INSM: Brensocatib and TPIP advances fuel growth, with major data and market expansions ahead - TradingView
Transcript : Insmed Incorporated Presents at Jefferies London Healthcare Conference 2025, Nov-18-2025 08 - MarketScreener
Here’s What Lifted Insmed Incorporated (INSM) in Q3 - Yahoo Finance
Insmed (INSM) Price Target Increased by 15.76% to 206.22 - Nasdaq
How Insmed Incorporated (IM8N) stock compares with tech leadersJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Insmed (BIT:1INSM) Price Target Increased by 19.33% to 179.30 - Nasdaq
Trend analysis for Insmed Incorporated this weekJuly 2025 Gainers & Comprehensive Market Scan Reports - newser.com
What drives Insmed Incorporated stock priceEconomic Impact on Stocks & Follow Top Performers in the Community - earlytimes.in
A Fresh Look at Insmed (INSM) Valuation After Recent Share Price Surge - Yahoo Finance
Insmed stock reaches 52-week high at 197.1 USD By Investing.com - Investing.com Nigeria
How Insmed Incorporated stock reacts to Fed rate cutsChart Signals & Comprehensive Market Scan Reports - newser.com
Insmed stock reaches 52-week high at 197.1 USD - Investing.com
What machine learning models say about Insmed IncorporatedPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Why Insmed Incorporated is moving todayJuly 2025 Market Mood & AI Powered Market Entry Strategies - newser.com
Insmed Strengthens Communities Worldwide During Fourth Annual Global Day of Good – Company Announcement - Financial Times
Finanzdaten der Insmed Inc-Aktie (INSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Insmed Inc-Aktie (INSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ANDERSON ELIZABETH M | Director |
Nov 14 '25 |
Sale |
195.87 |
10,000 |
1,958,700 |
63,729 |
1.27%
0.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):